The CREATE Wellness Study

NACompletedINTERVENTIONAL
Enrollment

647

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
DiabetesHeart DiseaseHypertensionDyslipidemia
Interventions
BEHAVIORAL

CREATE Wellness

Patients allocated to the intervention arm will receive three group sessions with between visit contacts designed to increase activation and engagement with their care plans. They will also continue to be enrolled in the KP PHASE program

OTHER

Usual Care Control

Patients allocated to the control arm will continue to receive usual care, including disease management within the KP PHASE program.

Trial Locations (1)

95119

Kaiser Permanente San Jose Sabrina Wood, BA (510) 891-3551 [email protected], San Jose

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Kaiser Permanente

OTHER

NCT02302612 - The CREATE Wellness Study | Biotech Hunter | Biotech Hunter